The fact that the better anti- tumor effect observed in rapamycin-treated mice was accompanied with a greater decrease in the phosphorylation status of P70S6K suggests a more effective mTOR pathway inhibition [19, 52, 53]. The gene discussed is RPS6KB1; the disease is neoplasm.